<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36044181</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-3524</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Neurotoxicity research</Title><ISOAbbreviation>Neurotox Res</ISOAbbreviation></Journal><ArticleTitle>CRISPR and iPSCs: Recent Developments and Future Perspectives in Neurodegenerative Disease Modelling, Research, and Therapeutics.</ArticleTitle><Pagination><StartPage>1597</StartPage><EndPage>1623</EndPage><MedlinePgn>1597-1623</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12640-022-00564-w</ELocationID><Abstract><AbstractText>Neurodegenerative diseases are prominent causes of pain, suffering, and death worldwide. Traditional approaches modelling neurodegenerative diseases are deficient, and therefore, improved strategies that effectively recapitulate the pathophysiological conditions of neurodegenerative diseases are the need of the hour. The generation of human-induced pluripotent stem cells (iPSCs) has transformed our ability to model neurodegenerative diseases in vitro and provide an unlimited source of cells (including desired neuronal cell types) for cell replacement therapy. Recently, CRISPR/Cas9-based genome editing has also been gaining popularity because of the flexibility they provide to generate and ablate disease phenotypes. In addition, the recent advancements in CRISPR/Cas9 technology enables researchers to seamlessly target and introduce precise modifications in the genomic DNA of different human cell lines, including iPSCs. CRISPR-iPSC-based disease modelling, therefore, allows scientists to recapitulate the pathological aspects of most neurodegenerative processes and investigate the role of pathological gene variants in healthy non-patient cell lines. This review outlines how iPSCs, CRISPR/Cas9, and CRISPR-iPSC-based approaches accelerate research on neurodegenerative diseases and take us closer to a cure for neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Amyotrophic Lateral Sclerosis, and so forth.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sen</LastName><ForeName>Tirthankar</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-4039-8036</Identifier><AffiliationInfo><Affiliation>Laboratory for Stem Cell Engineering and Regenerative Medicine, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati - 781039, Assam, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thummer</LastName><ForeName>Rajkumar P</ForeName><Initials>RP</Initials><Identifier Source="ORCID">0000-0002-4526-8364</Identifier><AffiliationInfo><Affiliation>Laboratory for Stem Cell Engineering and Regenerative Medicine, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati - 781039, Assam, India. rthu@iitg.ac.in.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>BT/PR16655/NER/95/132/2015</GrantID><Agency>by North Eastern Region - Biotechnology Programme Management Cell (NERBPMC), Department of Biotechnology, Government of India</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Neurotox Res</MedlineTA><NlmUniqueID>100929017</NlmUniqueID><ISSNLinking>1029-8428</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072669" MajorTopicYN="N">Gene Editing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clustered regularly interspaced short palindromic repeats</Keyword><Keyword MajorTopicYN="N">Disease modelling</Keyword><Keyword MajorTopicYN="N">Genome editing</Keyword><Keyword MajorTopicYN="N">Induced pluripotent stem cells</Keyword><Keyword MajorTopicYN="N">Neurodegenerative diseases</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>31</Day><Hour>11</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36044181</ArticleId><ArticleId IdType="pmc">PMC9428373</ArticleId><ArticleId IdType="doi">10.1007/s12640-022-00564-w</ArticleId><ArticleId IdType="pii">10.1007/s12640-022-00564-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abramzon YA, Fratta P, Traynor BJ, Chia R. The overlapping genetics of amyotrophic lateral sclerosis and frontotemporal dementia. Front Neurosci. 2020;14:42. doi: 10.3389/fnins.2020.00042.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00042</ArticleId><ArticleId IdType="pmc">PMC7012787</ArticleId><ArticleId IdType="pubmed">32116499</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler L, Boyer NP, Chen C et al (2015) The 11-cis retinal origins of lipofuscin in the retina. In: Progress in Molecular Biology and Translational Science. Elsevier, pp e1&#x2013;e12</Citation><ArticleIdList><ArticleId IdType="pubmed">26310175</ArticleId></ArticleIdList></Reference><Reference><Citation>Adli M. The CRISPR tool kit for genome editing and beyond. Nat Commun. 2018;9:1911. doi: 10.1038/s41467-018-04252-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-04252-2</ArticleId><ArticleId IdType="pmc">PMC5953931</ArticleId><ArticleId IdType="pubmed">29765029</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal A, Narayan G, Gogoi R, Thummer RP. Recent advances in the generation of &#x3b2;-cells from induced pluripotent stem cells as a potential cure for diabetes mellitus. In: Turksen K, editor. Cell Biology and Translational Medicine. Cham: Springer International Publishing; 2021. pp. 1&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">34426962</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahfeldt T, Ordureau A, Bell C, et al. Pathogenic pathways in early-onset autosomal recessive Parkinson&#x2019;s disease discovered using isogenic human dopaminergic neurons. Stem Cell Reports. 2020;14:75&#x2013;90. doi: 10.1016/j.stemcr.2019.12.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2019.12.005</ArticleId><ArticleId IdType="pmc">PMC6962705</ArticleId><ArticleId IdType="pubmed">31902706</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida S, Zhang Z, Coppola G, et al. Induced pluripotent stem cell models of progranulin-deficient frontotemporal dementia uncover specific reversible neuronal defects. Cell Rep. 2012;2:789&#x2013;798. doi: 10.1016/j.celrep.2012.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2012.09.007</ArticleId><ArticleId IdType="pmc">PMC3532907</ArticleId><ArticleId IdType="pubmed">23063362</ArticleId></ArticleIdList></Reference><Reference><Citation>Alok A, Sandhya D, Jogam P, et al. The rise of the CRISPR/Cpf1 system for efficient genome editing in plants. Front Plant Sci. 2020;11:264. doi: 10.3389/fpls.2020.00264.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpls.2020.00264</ArticleId><ArticleId IdType="pmc">PMC7136500</ArticleId><ArticleId IdType="pubmed">32296449</ArticleId></ArticleIdList></Reference><Reference><Citation>Amado DA, Davidson BL (2021) Gene therapy for ALS: a review. Mol Ther S1525001621001957.&#xa0;10.1016/j.ymthe.2021.04.008</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8636154</ArticleId><ArticleId IdType="pubmed">33839324</ArticleId></ArticleIdList></Reference><Reference><Citation>An MC, O&#x2019;Brien RN, Zhang N et al (2014) Polyglutamine disease modeling: epitope based screen for homologous recombination using CRISPR/Cas9 system. PLoS Currents 6.&#xa0;10.1371/currents.hd.0242d2e7ad72225efa72f6964589369a</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3994193</ArticleId><ArticleId IdType="pubmed">24761311</ArticleId></ArticleIdList></Reference><Reference><Citation>An MC, Zhang N, Scott G, et al. Genetic correction of Huntington&#x2019;s disease phenotypes in induced pluripotent stem cells. Cell Stem Cell. 2012;11:253&#x2013;263. doi: 10.1016/j.stem.2012.04.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2012.04.026</ArticleId><ArticleId IdType="pmc">PMC3608272</ArticleId><ArticleId IdType="pubmed">22748967</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade NS, Ramic M, Esanov R, et al. Dipeptide repeat proteins inhibit homology-directed DNA double strand break repair in C9ORF72 ALS/FTD. Mol Neurodegeneration. 2020;15:13. doi: 10.1186/s13024-020-00365-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00365-9</ArticleId><ArticleId IdType="pmc">PMC7041170</ArticleId><ArticleId IdType="pubmed">32093728</ArticleId></ArticleIdList></Reference><Reference><Citation>Arias-Fuenzalida J, Jarazo J, Qing X, et al. FACS-assisted CRISPR-Cas9 genome editing facilitates Parkinson&#x2019;s disease modeling. Stem Cell Reports. 2017;9:1423&#x2013;1431. doi: 10.1016/j.stemcr.2017.08.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.08.026</ArticleId><ArticleId IdType="pmc">PMC5830965</ArticleId><ArticleId IdType="pubmed">28988985</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariga H, Takahashi-Niki K, Kato I, et al. Neuroprotective function of DJ-1 in Parkinson&#x2019;s disease. Oxid Med Cell Longev. 2013;2013:e683920. doi: 10.1155/2013/683920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/683920</ArticleId><ArticleId IdType="pmc">PMC3671546</ArticleId><ArticleId IdType="pubmed">23766857</ArticleId></ArticleIdList></Reference><Reference><Citation>Attwood S, Edel M. iPS-Cell Technology and the problem of genetic instability&#x2014;can it ever be safe for clinical use? JCM. 2019;8:288. doi: 10.3390/jcm8030288.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8030288</ArticleId><ArticleId IdType="pmc">PMC6462964</ArticleId><ArticleId IdType="pubmed">30823421</ArticleId></ArticleIdList></Reference><Reference><Citation>Auluck PK, Caraveo G, Lindquist S. &#x3b1;-Synuclein: membrane interactions and toxicity in Parkinson&#x2019;s disease. Annu Rev Cell Dev Biol. 2010;26:211&#x2013;233. doi: 10.1146/annurev.cellbio.042308.113313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.cellbio.042308.113313</ArticleId><ArticleId IdType="pubmed">20500090</ArticleId></ArticleIdList></Reference><Reference><Citation>Babu M, Favretto F, de Opakua AI, et al. Proline/arginine dipeptide repeat polymers derail protein folding in amyotrophic lateral sclerosis. Nat Commun. 2021;12:3396. doi: 10.1038/s41467-021-23691-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23691-y</ArticleId><ArticleId IdType="pmc">PMC8184751</ArticleId><ArticleId IdType="pubmed">34099711</ArticleId></ArticleIdList></Reference><Reference><Citation>Banno H, Katsuno M, Suzuki K, et al. Neuropathology and therapeutic intervention in spinal and bulbar muscular atrophy. IJMS. 2009;10:1000&#x2013;1012. doi: 10.3390/ijms10031000.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms10031000</ArticleId><ArticleId IdType="pmc">PMC2672015</ArticleId><ArticleId IdType="pubmed">19399234</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber RC. The genetics of Alzheimer&#x2019;s disease. Scientifica. 2012;2012:1&#x2013;14. doi: 10.6064/2012/246210.</Citation><ArticleIdList><ArticleId IdType="doi">10.6064/2012/246210</ArticleId><ArticleId IdType="pmc">PMC3820554</ArticleId><ArticleId IdType="pubmed">24278680</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrangou R, Fremaux C, Deveau H, et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science. 2007;315:1709&#x2013;1712. doi: 10.1126/science.1138140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1138140</ArticleId><ArticleId IdType="pubmed">17379808</ArticleId></ArticleIdList></Reference><Reference><Citation>Benam KH, Dauth S, Hassell B, et al. Engineered in vitro disease models. Annu Rev Pathol Mech Dis. 2015;10:195&#x2013;262. doi: 10.1146/annurev-pathol-012414-040418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathol-012414-040418</ArticleId><ArticleId IdType="pubmed">25621660</ArticleId></ArticleIdList></Reference><Reference><Citation>Beylina A, Langston RG, Rosen D, et al. Generation of fourteen isogenic cell lines for Parkinson&#x2019;s disease-associated leucine-rich repeat kinase (LRRK2) Stem Cell Research. 2021;53:102354. doi: 10.1016/j.scr.2021.102354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2021.102354</ArticleId><ArticleId IdType="pmc">PMC8314873</ArticleId><ArticleId IdType="pubmed">34087985</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilican B, Serio A, Barmada SJ, et al. Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proc Natl Acad Sci. 2012;109:5803&#x2013;5808. doi: 10.1073/pnas.1202922109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1202922109</ArticleId><ArticleId IdType="pmc">PMC3326463</ArticleId><ArticleId IdType="pubmed">22451909</ArticleId></ArticleIdList></Reference><Reference><Citation>Bin Moon S, Lee JM, Kang JG, et al. Highly efficient genome editing by CRISPR-Cpf1 using CRISPR RNA with a uridinylate-rich 3&#x2032;-overhang. Nat Commun. 2018;9:3651. doi: 10.1038/s41467-018-06129-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06129-w</ArticleId><ArticleId IdType="pmc">PMC6128929</ArticleId><ArticleId IdType="pubmed">30194297</ArticleId></ArticleIdList></Reference><Reference><Citation>Birger A, Ben-Dor I, Ottolenghi M, et al. Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity. EBioMedicine. 2019;50:274&#x2013;289. doi: 10.1016/j.ebiom.2019.11.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2019.11.026</ArticleId><ArticleId IdType="pmc">PMC6921360</ArticleId><ArticleId IdType="pubmed">31787569</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolognin S, Foss&#xe9;pr&#xe9; M, Qing X, et al. 3D cultures of Parkinson&#x2019;s disease-specific dopaminergic neurons for high content phenotyping and drug testing. Adv Sci. 2019;6:1800927. doi: 10.1002/advs.201800927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/advs.201800927</ArticleId><ArticleId IdType="pmc">PMC6325628</ArticleId><ArticleId IdType="pubmed">30643711</ArticleId></ArticleIdList></Reference><Reference><Citation>Booth HDE, Hirst WD, Wade-Martins R. The role of astrocyte dysfunction in Parkinson&#x2019;s disease pathogenesis. Trends Neurosci. 2017;40:358&#x2013;370. doi: 10.1016/j.tins.2017.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2017.04.001</ArticleId><ArticleId IdType="pmc">PMC5462417</ArticleId><ArticleId IdType="pubmed">28527591</ArticleId></ArticleIdList></Reference><Reference><Citation>Borgohain MP, Haridhasapavalan KK, Dey C, et al. An insight into DNA-free reprogramming approaches to generate integration-free induced pluripotent stem cells for prospective biomedical applications. Stem Cell Rev Rep. 2019;15:286&#x2013;313. doi: 10.1007/s12015-018-9861-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-018-9861-6</ArticleId><ArticleId IdType="pubmed">30417242</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowerman M, Murray LM, Scamps F, et al. Pathogenic commonalities between spinal muscular atrophy and amyotrophic lateral sclerosis: converging roads to therapeutic development. Eur J Med Genet. 2018;61:685&#x2013;698. doi: 10.1016/j.ejmg.2017.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmg.2017.12.001</ArticleId><ArticleId IdType="pubmed">29313812</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradshaw AV, Campbell P, Schapira AHV, et al. The PINK1&#x2014;Parkin mitophagy signalling pathway is not functional in peripheral blood mononuclear cells. PLoS ONE. 2021;16:e0259903. doi: 10.1371/journal.pone.0259903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0259903</ArticleId><ArticleId IdType="pmc">PMC8584748</ArticleId><ArticleId IdType="pubmed">34762687</ArticleId></ArticleIdList></Reference><Reference><Citation>Braems E, Swinnen B, Van Den Bosch L. C9orf72 loss-of-function: a trivial, stand-alone or additive mechanism in C9 ALS/FTD? Acta Neuropathol. 2020;140:625&#x2013;643. doi: 10.1007/s00401-020-02214-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02214-x</ArticleId><ArticleId IdType="pmc">PMC7547039</ArticleId><ArticleId IdType="pubmed">32876811</ArticleId></ArticleIdList></Reference><Reference><Citation>Braems E, Tziortzouda P, Van Den Bosch L. Exploring the alternative: fish, flies and worms as preclinical models for ALS. Neurosci Lett. 2021;759:136041. doi: 10.1016/j.neulet.2021.136041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2021.136041</ArticleId><ArticleId IdType="pubmed">34118308</ArticleId></ArticleIdList></Reference><Reference><Citation>Bunk J, Prieto Huarcaya S, Drobny A, et al. Cathepsin D variants associated with neurodegenerative diseases show dysregulated functionality and modified &#x3b1;-synuclein degradation properties. Front Cell Dev Biol. 2021;9:581805. doi: 10.3389/fcell.2021.581805.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2021.581805</ArticleId><ArticleId IdType="pmc">PMC7928348</ArticleId><ArticleId IdType="pubmed">33681191</ArticleId></ArticleIdList></Reference><Reference><Citation>Burk K, Pasterkamp RJ. Disrupted neuronal trafficking in amyotrophic lateral sclerosis. Acta Neuropathol. 2019;137:859&#x2013;877. doi: 10.1007/s00401-019-01964-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01964-7</ArticleId><ArticleId IdType="pmc">PMC6531423</ArticleId><ArticleId IdType="pubmed">30721407</ArticleId></ArticleIdList></Reference><Reference><Citation>Burnight ER, Bohrer LR, Giacalone JC, et al. CRISPR-Cas9-mediated correction of the 1.02 kb common deletion in CLN3 in induced pluripotent stem cells from patients with batten disease. CRISPR J. 2018;1:75&#x2013;87. doi: 10.1089/crispr.2017.0015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/crispr.2017.0015</ArticleId><ArticleId IdType="pmc">PMC6319325</ArticleId><ArticleId IdType="pubmed">31021193</ArticleId></ArticleIdList></Reference><Reference><Citation>Burstein SR, Valsecchi F, Kawamata H, et al. In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions. Hum Mol Genet. 2018;27:160&#x2013;177. doi: 10.1093/hmg/ddx397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx397</ArticleId><ArticleId IdType="pmc">PMC5886281</ArticleId><ArticleId IdType="pubmed">29112723</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappello V, Francolini M. Neuromuscular junction dismantling in amyotrophic lateral sclerosis. IJMS. 2017;18:2092. doi: 10.3390/ijms18102092.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18102092</ArticleId><ArticleId IdType="pmc">PMC5666774</ArticleId><ArticleId IdType="pubmed">28972545</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlson-Stevermer J, Kelso R, Kadina A, et al. CRISPRoff enables spatio-temporal control of CRISPR editing. Nat Commun. 2020;11:5041. doi: 10.1038/s41467-020-18853-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18853-3</ArticleId><ArticleId IdType="pmc">PMC7542431</ArticleId><ArticleId IdType="pubmed">33028827</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll CM, Li Y-M. Physiological and pathological roles of the &#x3b3;-secretase complex. Brain Res Bull. 2016;126:199&#x2013;206. doi: 10.1016/j.brainresbull.2016.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2016.04.019</ArticleId><ArticleId IdType="pmc">PMC5436903</ArticleId><ArticleId IdType="pubmed">27133790</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen CX-Q, You Z, Abdian N et al (2022) Generation of homozygous PRKN, PINK1 and double PINK1/PRKN knockout cell lines from healthy induced pluripotent stem cells using CRISPR/Cas9 editing. Stem Cell Res 62:102806.&#xa0;10.1016/j.scr.2022.102806</Citation><ArticleIdList><ArticleId IdType="pubmed">35561458</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JJ. Overview of current and emerging therapies for amyotrophic lateral sclerosis. Am J Manag Care. 2020;26:S191&#x2013;S197. doi: 10.37765/ajmc.2020.88483.</Citation><ArticleIdList><ArticleId IdType="doi">10.37765/ajmc.2020.88483</ArticleId><ArticleId IdType="pubmed">32840332</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Park JE, Paa P, et al. Programmable C: G to G: C genome editing with CRISPR-Cas9-directed base excision repair proteins. Nat Commun. 2021;12:1384. doi: 10.1038/s41467-021-21559-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21559-9</ArticleId><ArticleId IdType="pmc">PMC7925527</ArticleId><ArticleId IdType="pubmed">33654077</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Luo Z, Ward C et al (2020) Generation of two LRRK2 homozygous knockout human induced pluripotent stem cell lines using CRISPR/Cas9. Stem Cell Res 45:101804. 10.1016/j.scr.2020.101804</Citation><ArticleIdList><ArticleId IdType="pubmed">32339904</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng T-L, Li S, Yuan B, et al. Expanding C-T base editing toolkit with diversified cytidine deaminases. Nat Commun. 2019;10:3612. doi: 10.1038/s41467-019-11562-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11562-6</ArticleId><ArticleId IdType="pmc">PMC6689024</ArticleId><ArticleId IdType="pubmed">31399578</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi B, O&#x2019;Connell JD, Iocolano AD, et al. The neurodegenerative diseases ALS and SMA are linked at the molecular level via the ASC-1 complex. Nucleic Acids Res. 2018;46:11939&#x2013;11951. doi: 10.1093/nar/gky1093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1093</ArticleId><ArticleId IdType="pmc">PMC6294556</ArticleId><ArticleId IdType="pubmed">30398641</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinta SJ, Andersen JK. Dopaminergic neurons. Int J Biochem Cell Biol. 2005;37:942&#x2013;946. doi: 10.1016/j.biocel.2004.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2004.09.009</ArticleId><ArticleId IdType="pubmed">15743669</ArticleId></ArticleIdList></Reference><Reference><Citation>Claes C, Danhash EP, Hasselmann J, et al. Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer&#x2019;s disease. Mol Neurodegener. 2021;16:50. doi: 10.1186/s13024-021-00473-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00473-0</ArticleId><ArticleId IdType="pmc">PMC8305935</ArticleId><ArticleId IdType="pubmed">34301296</ArticleId></ArticleIdList></Reference><Reference><Citation>Coelho MA, De Braekeleer E, Firth M, et al. CRISPR GUARD protects off-target sites from Cas9 nuclease activity using short guide RNAs. Nat Commun. 2020;11:4132. doi: 10.1038/s41467-020-17952-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-17952-5</ArticleId><ArticleId IdType="pmc">PMC7431537</ArticleId><ArticleId IdType="pubmed">32807781</ArticleId></ArticleIdList></Reference><Reference><Citation>Comley LH, Nijssen J, Frost-Nylen J, Hedlund E. Cross-disease comparison of amyotrophic lateral sclerosis and spinal muscular atrophy reveals conservation of selective vulnerability but differential neuromuscular junction pathology: selective Vulnerability in ALS and SMA. J Comp Neurol. 2016;524:1424&#x2013;1442. doi: 10.1002/cne.23917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.23917</ArticleId><ArticleId IdType="pmc">PMC5063101</ArticleId><ArticleId IdType="pubmed">26502195</ArticleId></ArticleIdList></Reference><Reference><Citation>Cornblath EJ, Robinson JL, Irwin DJ, et al. Defining and predicting transdiagnostic categories of neurodegenerative disease. Nat Biomed Eng. 2020;4:787&#x2013;800. doi: 10.1038/s41551-020-0593-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41551-020-0593-y</ArticleId><ArticleId IdType="pmc">PMC7946378</ArticleId><ArticleId IdType="pubmed">32747831</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowell V, Houghton R, Tomar A, et al. Modeling manifest Huntington&#x2019;s disease prevalence using diagnosed incidence and survival time. Neuroepidemiology. 2021;55:361&#x2013;368. doi: 10.1159/000516767.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000516767</ArticleId><ArticleId IdType="pubmed">34350853</ArticleId></ArticleIdList></Reference><Reference><Citation>Csobonyeiova M, Polak S, Danisovic L. Recent overview of the use of iPSCs Huntington&#x2019;s disease modeling and therapy. IJMS. 2020;21:2239. doi: 10.3390/ijms21062239.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21062239</ArticleId><ArticleId IdType="pmc">PMC7139425</ArticleId><ArticleId IdType="pubmed">32213859</ArticleId></ArticleIdList></Reference><Reference><Citation>Dabrowska M, Ciolak A, Kozlowska E, et al. Generation of new isogenic models of Huntington&#x2019;s disease using CRISPR-Cas9 technology. IJMS. 2020;21:1854. doi: 10.3390/ijms21051854.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21051854</ArticleId><ArticleId IdType="pmc">PMC7084361</ArticleId><ArticleId IdType="pubmed">32182692</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis AA, Leyns CEG, Holtzman DM. Intercellular spread of protein aggregates in neurodegenerative disease. Annu Rev Cell Dev Biol. 2018;34:545&#x2013;568. doi: 10.1146/annurev-cellbio-100617-062636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cellbio-100617-062636</ArticleId><ArticleId IdType="pmc">PMC6350082</ArticleId><ArticleId IdType="pubmed">30044648</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawson TM, Golde TE, Lagier-Tourenne C. Animal models of neurodegenerative diseases. Nat Neurosci. 2018;21:1370&#x2013;1379. doi: 10.1038/s41593-018-0236-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0236-8</ArticleId><ArticleId IdType="pmc">PMC6615039</ArticleId><ArticleId IdType="pubmed">30250265</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira GAP, Silva JL. Alpha-synuclein stepwise aggregation reveals features of an early onset mutation in Parkinson&#x2019;s disease. Commun Biol. 2019;2:374. doi: 10.1038/s42003-019-0598-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-019-0598-9</ArticleId><ArticleId IdType="pmc">PMC6789109</ArticleId><ArticleId IdType="pubmed">31633065</ArticleId></ArticleIdList></Reference><Reference><Citation>Deinsberger J, Reisinger D, Weber B (2020) Global trends in clinical trials involving pluripotent stem cells: a systematic multi-database analysis. npj Regen Med 5:15. 10.1038/s41536-020-00100-4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7486930</ArticleId><ArticleId IdType="pubmed">32983575</ArticleId></ArticleIdList></Reference><Reference><Citation>Dettmer U, Newman AJ, Soldner F, et al. Parkinson-causing &#x3b1;-synuclein missense mutations shift native tetramers to monomers as a mechanism for disease initiation. Nat Commun. 2015;6:7314. doi: 10.1038/ncomms8314.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms8314</ArticleId><ArticleId IdType="pmc">PMC4490410</ArticleId><ArticleId IdType="pubmed">26076669</ArticleId></ArticleIdList></Reference><Reference><Citation>DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer&#x2019;s disease. Mol Neurodegeneration. 2019;14:32. doi: 10.1186/s13024-019-0333-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0333-5</ArticleId><ArticleId IdType="pmc">PMC6679484</ArticleId><ArticleId IdType="pubmed">31375134</ArticleId></ArticleIdList></Reference><Reference><Citation>Devine MJ, Ryten M, Vodicka P, et al. Parkinson&#x2019;s disease induced pluripotent stem cells with triplication of the &#x3b1;-synuclein locus. Nat Commun. 2011;2:440. doi: 10.1038/ncomms1453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms1453</ArticleId><ArticleId IdType="pmc">PMC3265381</ArticleId><ArticleId IdType="pubmed">21863007</ArticleId></ArticleIdList></Reference><Reference><Citation>Dey C, Narayan G, Krishna Kumar H et al (2017) Cell-penetrating peptides as a tool to deliver biologically active recombinant proteins to generate transgene-free induced pluripotent stem cells. Stud Stem Cells Res Ther 3:006&#x2013;015. 10.17352/sscrt.000011</Citation></Reference><Reference><Citation>Dey C, Raina K, Haridhasapavalan KK, et al. Chapter 9 - An overview of reprogramming approaches to derive integration-free induced pluripotent stem cells for prospective biomedical applications. In: Birbrair A, et al., editors. Recent Advances in iPSC Technology. Academic Press; 2021. pp. 231&#x2013;287.</Citation></Reference><Reference><Citation>Dey C, Raina K, Thool M, et al. Chapter 2 - Auxiliary pluripotency-associated genes and their contributions in the generation of induced pluripotent stem cells. In: Birbrair A, et al., editors. Molecular Players in iPSC Technology. Academic Press; 2022. pp. 29&#x2013;94.</Citation></Reference><Reference><Citation>di Domenico A, Carola G, Calatayud C, et al. Patient-specific iPSC-derived astrocytes contribute to non-cell-autonomous neurodegeneration in Parkinson&#x2019;s disease. Stem Cell Rep. 2019;12:213&#x2013;229. doi: 10.1016/j.stemcr.2018.12.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2018.12.011</ArticleId><ArticleId IdType="pmc">PMC6372974</ArticleId><ArticleId IdType="pubmed">30639209</ArticleId></ArticleIdList></Reference><Reference><Citation>Donowitz M, Turner JR, Verkman AS, Zachos NC. Current and potential future applications of human stem cell models in drug development. J Clin Investig. 2020;130:3342&#x2013;3344. doi: 10.1172/JCI138645.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI138645</ArticleId><ArticleId IdType="pmc">PMC7324189</ArticleId><ArticleId IdType="pubmed">32452833</ArticleId></ArticleIdList></Reference><Reference><Citation>Doss MX, Sachinidis A. Current challenges of iPSC-based disease modeling and therapeutic implications. Cells. 2019;8:403. doi: 10.3390/cells8050403.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8050403</ArticleId><ArticleId IdType="pmc">PMC6562607</ArticleId><ArticleId IdType="pubmed">31052294</ArticleId></ArticleIdList></Reference><Reference><Citation>Dur&#xe3;es F, Pinto M, Sousa E. Old drugs as new treatments for neurodegenerative diseases. Pharmaceuticals. 2018;11:44. doi: 10.3390/ph11020044.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph11020044</ArticleId><ArticleId IdType="pmc">PMC6027455</ArticleId><ArticleId IdType="pubmed">29751602</ArticleId></ArticleIdList></Reference><Reference><Citation>Espay AJ, Litvan I. Parkinsonism and frontotemporal dementia: the clinical overlap. J Mol Neurosci. 2011;45:343&#x2013;349. doi: 10.1007/s12031-011-9632-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-011-9632-1</ArticleId><ArticleId IdType="pmc">PMC3324113</ArticleId><ArticleId IdType="pubmed">21892619</ArticleId></ArticleIdList></Reference><Reference><Citation>Estrada-Cuzcano A, Martin S, Chamova T, et al. Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78) Brain. 2017;140:287&#x2013;305. doi: 10.1093/brain/aww307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aww307</ArticleId><ArticleId IdType="pmc">PMC5278306</ArticleId><ArticleId IdType="pubmed">28137957</ArticleId></ArticleIdList></Reference><Reference><Citation>Fares MB, Jagannath S, Lashuel HA. Reverse engineering Lewy bodies: how far have we come and how far can we go? Nat Rev Neurosci. 2021;22:111&#x2013;131. doi: 10.1038/s41583-020-00416-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41583-020-00416-6</ArticleId><ArticleId IdType="pubmed">33432241</ArticleId></ArticleIdList></Reference><Reference><Citation>Fauerbach JA, Jovin TM. Pre-aggregation kinetics and intermediates of &#x3b1;-synuclein monitored by the ESIPT probe 7MFE. Eur Biophys J. 2018;47:345&#x2013;362. doi: 10.1007/s00249-017-1272-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00249-017-1272-0</ArticleId><ArticleId IdType="pmc">PMC5982440</ArticleId><ArticleId IdType="pubmed">29255947</ArticleId></ArticleIdList></Reference><Reference><Citation>Faustino Martins J-M, Fischer C, Urzi A, et al. Self-organizing 3D human trunk neuromuscular organoids. Cell Stem Cell. 2020;26:172&#x2013;186.e6. doi: 10.1016/j.stem.2019.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2019.12.007</ArticleId><ArticleId IdType="pubmed">31956040</ArticleId></ArticleIdList></Reference><Reference><Citation>Feigin VL, Nichols E, Alam T, et al. Global, regional, and national burden of neurological disorders, 1990&#x2013;2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:459&#x2013;480. doi: 10.1016/S1474-4422(18)30499-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30499-X</ArticleId><ArticleId IdType="pmc">PMC6459001</ArticleId><ArticleId IdType="pubmed">30879893</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng H, Li Q, Margolis RL, Li PP (2021) Generation of a human induced pluripotent stem cell line JHUi003-A with homozygous mutation for spinocerebellar ataxia type 12 using genome editing. Stem Cell Res 53:102346. 10.1016/j.scr.2021.102346</Citation><ArticleIdList><ArticleId IdType="pubmed">34087983</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J, Perera G, Bhadbhade M, et al. Autophagy activation promotes clearance of &#x3b1;-synuclein inclusions in fibril-seeded human neural cells. J Biol Chem. 2019;294:14241&#x2013;14256. doi: 10.1074/jbc.RA119.008733.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA119.008733</ArticleId><ArticleId IdType="pmc">PMC6768637</ArticleId><ArticleId IdType="pubmed">31375560</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh S, Lippa CF. Clinical subtypes of frontotemporal dementia. Am J Alzheimers Dis Other Demen. 2015;30:653&#x2013;661. doi: 10.1177/1533317513494442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1533317513494442</ArticleId><ArticleId IdType="pubmed">23813692</ArticleId></ArticleIdList></Reference><Reference><Citation>Giri M, L&#xfc; Y, Zhang M (2016) Genes associated with Alzheimer&#x2019;s disease: an overview and current status. CIA 665.&#xa0;10.2147/CIA.S105769</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4876682</ArticleId><ArticleId IdType="pubmed">27274215</ArticleId></ArticleIdList></Reference><Reference><Citation>Gohil N, Bhattacharjee G, Lam NL et al (2021) CRISPR-Cas systems: challenges and future prospects. In: Progress in Molecular Biology and Translational Science. Elsevier, pp 141&#x2013;151</Citation><ArticleIdList><ArticleId IdType="pubmed">33934835</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Giro G, Arias-Fuenzalida J, Jarazo J, et al. Synapse alterations precede neuronal damage and storage pathology in a human cerebral organoid model of CLN3-juvenile neuronal ceroid lipofuscinosis. Acta Neuropathol Commun. 2019;7:222. doi: 10.1186/s40478-019-0871-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0871-7</ArticleId><ArticleId IdType="pmc">PMC6937812</ArticleId><ArticleId IdType="pubmed">31888773</ArticleId></ArticleIdList></Reference><Reference><Citation>Govoni S, Gasparini L, Racchi M, Trabucchi M. Peripheral cells as an investigational tool for Alzheimer&#x2019;s disease. Life Sci. 1996;59:461&#x2013;468. doi: 10.1016/0024-3205(96)00325-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0024-3205(96)00325-6</ArticleId><ArticleId IdType="pubmed">8761334</ArticleId></ArticleIdList></Reference><Reference><Citation>Grochowska MM, Carreras Mascaro A, Boumeester V, et al. LRP10 interacts with SORL1 in the intracellular vesicle trafficking pathway in non-neuronal brain cells and localises to Lewy bodies in Parkinson&#x2019;s disease and dementia with Lewy bodies. Acta Neuropathol. 2021;142:117&#x2013;137. doi: 10.1007/s00401-021-02313-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-021-02313-3</ArticleId><ArticleId IdType="pmc">PMC8217053</ArticleId><ArticleId IdType="pubmed">33913039</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunseich C, Rinaldi C, Fischbeck K. Spinal and bulbar muscular atrophy: pathogenesis and clinical management. Oral Dis. 2014;20:6&#x2013;9. doi: 10.1111/odi.12121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/odi.12121</ArticleId><ArticleId IdType="pmc">PMC4284073</ArticleId><ArticleId IdType="pubmed">23656576</ArticleId></ArticleIdList></Reference><Reference><Citation>Haavik J, Toska K. Tyrosine hydroxylase and Parkinson&#x2019;s disease. Mol Neurobiol. 1998;16:285&#x2013;309. doi: 10.1007/BF02741387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02741387</ArticleId><ArticleId IdType="pubmed">9626667</ArticleId></ArticleIdList></Reference><Reference><Citation>Hancock-Cerutti W, Wu Z, Xu P, et al. ER-lysosome lipid transfer protein VPS13C/PARK23 prevents aberrant mtDNA-dependent STING signaling. J Cell Biol. 2022;221:e202106046. doi: 10.1083/jcb.202106046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.202106046</ArticleId><ArticleId IdType="pmc">PMC9170524</ArticleId><ArticleId IdType="pubmed">35657605</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanss Z, Boussaad I, Jarazo J et al (2020) Quality control strategy for CRISPR-Cas9-based gene editing complicated by a pseudogene. Front Genet 10.&#xa0;10.3389/fgene.2019.01297</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6961559</ArticleId><ArticleId IdType="pubmed">31998363</ArticleId></ArticleIdList></Reference><Reference><Citation>Hargus G, Ehrlich M, Hallmann A-L, Kuhlmann T. Human stem cell models of neurodegeneration: a novel approach to study mechanisms of disease development. Acta Neuropathol. 2014;127:151&#x2013;173. doi: 10.1007/s00401-013-1222-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1222-6</ArticleId><ArticleId IdType="pubmed">24306942</ArticleId></ArticleIdList></Reference><Reference><Citation>Haridhasapavalan KK, Borgohain MP, Dey C, et al. An insight into non-integrative gene delivery approaches to generate transgene-free induced pluripotent stem cells. Gene. 2019;686:146&#x2013;159. doi: 10.1016/j.gene.2018.11.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2018.11.069</ArticleId><ArticleId IdType="pubmed">30472380</ArticleId></ArticleIdList></Reference><Reference><Citation>Haridhasapavalan KK, Raina K, Dey C, et al. An insight into reprogramming barriers to iPSC generation. Stem Cell Rev Rep. 2020;16:56&#x2013;81. doi: 10.1007/s12015-019-09931-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-019-09931-1</ArticleId><ArticleId IdType="pubmed">31758374</ArticleId></ArticleIdList></Reference><Reference><Citation>Harjuhaahto S, Rasila TS, Molchanova SM, et al. ALS and Parkinson&#x2019;s disease genes CHCHD10 and CHCHD2 modify synaptic transcriptomes in human iPSC-derived motor neurons. Neurobiol Dis. 2020;141:104940. doi: 10.1016/j.nbd.2020.104940.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104940</ArticleId><ArticleId IdType="pubmed">32437855</ArticleId></ArticleIdList></Reference><Reference><Citation>Haston KM, Finkbeiner S. Clinical trials in a dish: the potential of pluripotent stem cells to develop therapies for neurodegenerative diseases. Annu Rev Pharmacol Toxicol. 2016;56:489&#x2013;510. doi: 10.1146/annurev-pharmtox-010715-103548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pharmtox-010715-103548</ArticleId><ArticleId IdType="pmc">PMC4868344</ArticleId><ArticleId IdType="pubmed">26514199</ArticleId></ArticleIdList></Reference><Reference><Citation>Heman-Ackah SM, Bassett AR, Wood MJA. Precision modulation of neurodegenerative disease-related gene expression in human iPSC-derived neurons. Sci Rep. 2016;6:28420. doi: 10.1038/srep28420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep28420</ArticleId><ArticleId IdType="pmc">PMC4920027</ArticleId><ArticleId IdType="pubmed">27341390</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez D, Morgan Schlicht S, Daniszewski M et al (2021) Generation of a gene-corrected human isogenic iPSC line from an Alzheimer&#x2019;s disease iPSC line carrying the London mutation in APP (V717I). Stem Cell Res 53:102373. 10.1016/j.scr.2021.102373</Citation><ArticleIdList><ArticleId IdType="pubmed">34088002</ArticleId></ArticleIdList></Reference><Reference><Citation>Hofmann JW, Seeley WW, Huang EJ. RNA binding proteins and the pathogenesis of frontotemporal lobar degeneration. Annu Rev Pathol Mech Dis. 2019;14:469&#x2013;495. doi: 10.1146/annurev-pathmechdis-012418-012955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathmechdis-012418-012955</ArticleId><ArticleId IdType="pmc">PMC6731550</ArticleId><ArticleId IdType="pubmed">30355151</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoshina A, Kawamoto T, Sueta S-I, et al. Development of new method to enrich human iPSC-derived renal progenitors using cell surface markers. Sci Rep. 2018;8:6375. doi: 10.1038/s41598-018-24714-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-24714-3</ArticleId><ArticleId IdType="pmc">PMC5913312</ArticleId><ArticleId IdType="pubmed">29686294</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X, Mao C, Fan L, et al. Modeling Parkinson&#x2019;s disease using induced pluripotent stem cells. Stem Cells Int. 2020;2020:1&#x2013;15. doi: 10.1155/2020/1061470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2020/1061470</ArticleId><ArticleId IdType="pmc">PMC7091557</ArticleId><ArticleId IdType="pubmed">32256606</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C-Y, Liu C-L, Ting C-Y, et al. Human iPSC banking: barriers and opportunities. J Biomed Sci. 2019;26:87. doi: 10.1186/s12929-019-0578-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12929-019-0578-x</ArticleId><ArticleId IdType="pmc">PMC6819403</ArticleId><ArticleId IdType="pubmed">31660969</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung C, Tuck E, Stubbs V, et al. SORL1 deficiency in human excitatory neurons causes APP-dependent defects in the endolysosome-autophagy network. Cell Rep. 2021;35:109259. doi: 10.1016/j.celrep.2021.109259.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109259</ArticleId><ArticleId IdType="pmc">PMC8220253</ArticleId><ArticleId IdType="pubmed">34133918</ArticleId></ArticleIdList></Reference><Reference><Citation>Iannuzzi F, Frisardi V, Annunziato L, Matrone C. Might fibroblasts from patients with Alzheimer&#x2019;s disease reflect the brain pathology? A Focus on the Increased Phosphorylation of Amyloid Precursor Protein Tyr682 Residue. Brain Sci. 2021;11:103. doi: 10.3390/brainsci11010103.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11010103</ArticleId><ArticleId IdType="pmc">PMC7828817</ArticleId><ArticleId IdType="pubmed">33466666</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue K (2021) CRISPR-activated patient fibroblasts for modeling of familial Alzheimer&#x2019;s disease. Neurosci Res S0168010221000717.&#xa0;10.1016/j.neures.2021.03.008</Citation><ArticleIdList><ArticleId IdType="pubmed">33819561</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue K, Oliveira LMA, Abeliovich A. CRISPR transcriptional activation analysis unmasks an occult &#x3b3;-secretase processivity defect in familial Alzheimer&#x2019;s disease skin fibroblasts. Cell Rep. 2017;21:1727&#x2013;1736. doi: 10.1016/j.celrep.2017.10.075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.10.075</ArticleId><ArticleId IdType="pmc">PMC5704930</ArticleId><ArticleId IdType="pubmed">29141208</ArticleId></ArticleIdList></Reference><Reference><Citation>Israel MA, Yuan SH, Bardy C, et al. Probing sporadic and familial Alzheimer&#x2019;s disease using induced pluripotent stem cells. Nature. 2012;482:216&#x2013;220. doi: 10.1038/nature10821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10821</ArticleId><ArticleId IdType="pmc">PMC3338985</ArticleId><ArticleId IdType="pubmed">22278060</ArticleId></ArticleIdList></Reference><Reference><Citation>Jansen R, Embden JDV, Gaastra W, Schouls LM. Identification of genes that are associated with DNA repeats in prokaryotes. Mol Microbiol. 2002;43:1565&#x2013;1575. doi: 10.1046/j.1365-2958.2002.02839.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2958.2002.02839.x</ArticleId><ArticleId IdType="pubmed">11952905</ArticleId></ArticleIdList></Reference><Reference><Citation>Japtok J, Lojewski X, Naumann M, et al. Stepwise acquirement of hallmark neuropathology in FUS-ALS iPSC models depends on mutation type and neuronal aging. Neurobiol Dis. 2015;82:420&#x2013;429. doi: 10.1016/j.nbd.2015.07.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.07.017</ArticleId><ArticleId IdType="pubmed">26253605</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang H, Ren Y, Yuen EY, et al. Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells. Nat Commun. 2012;3:668. doi: 10.1038/ncomms1669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms1669</ArticleId><ArticleId IdType="pmc">PMC3498452</ArticleId><ArticleId IdType="pubmed">22314364</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang S, Wen N, Li Z, et al. Integrative system biology analyses of CRISPR-edited iPSC-derived neurons and human brains reveal deficiencies of presynaptic signaling in FTLD and PSP. Transl Psychiatry. 2018;8:265. doi: 10.1038/s41398-018-0319-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-018-0319-z</ArticleId><ArticleId IdType="pmc">PMC6293323</ArticleId><ArticleId IdType="pubmed">30546007</ArticleId></ArticleIdList></Reference><Reference><Citation>Jongh R, Spijkers XM, Pasteuning-Vuhman S, et al. Neuromuscular junction-on-a-chip: ALS disease modeling and read-out development in microfluidic devices. J Neurochem. 2021;157:393&#x2013;412. doi: 10.1111/jnc.15289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15289</ArticleId><ArticleId IdType="pubmed">33382092</ArticleId></ArticleIdList></Reference><Reference><Citation>Kajiwara M, Aoi T, Okita K, et al. Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells. Proc Natl Acad Sci. 2012;109:12538&#x2013;12543. doi: 10.1073/pnas.1209979109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1209979109</ArticleId><ArticleId IdType="pmc">PMC3411998</ArticleId><ArticleId IdType="pubmed">22802639</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalia LV, Lang AE. Parkinson&#x2019;s disease. Lancet. 2015;386:896&#x2013;912. doi: 10.1016/S0140-6736(14)61393-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)61393-3</ArticleId><ArticleId IdType="pubmed">25904081</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke M, Chong C-M, Su H. Using induced pluripotent stem cells for modeling Parkinson&#x2019;s disease. WJSC. 2019;11:634&#x2013;649. doi: 10.4252/wjsc.v11.i9.634.</Citation><ArticleIdList><ArticleId IdType="doi">10.4252/wjsc.v11.i9.634</ArticleId><ArticleId IdType="pmc">PMC6789186</ArticleId><ArticleId IdType="pubmed">31616540</ArticleId></ArticleIdList></Reference><Reference><Citation>Killick R, Ribe EM, Al-Shawi R, et al. Clusterin regulates &#x3b2;-amyloid toxicity via Dickkopf-1-driven induction of the wnt&#x2013;PCP&#x2013;JNK pathway. Mol Psychiatry. 2014;19:88&#x2013;98. doi: 10.1038/mp.2012.163.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2012.163</ArticleId><ArticleId IdType="pmc">PMC3873038</ArticleId><ArticleId IdType="pubmed">23164821</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim BW, Ryu J, Jeong YE, et al. Human motor neurons with SOD1-G93A mutation generated from CRISPR/Cas9 gene-edited iPSCs develop pathological features of amyotrophic lateral sclerosis. Front Cell Neurosci. 2020;14:604171. doi: 10.3389/fncel.2020.604171.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.604171</ArticleId><ArticleId IdType="pmc">PMC7710664</ArticleId><ArticleId IdType="pubmed">33328898</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G, Gautier O, Tassoni-Tsuchida E, et al. ALS genetics: gains, losses, and implications for future therapies. Neuron. 2020;108:822&#x2013;842. doi: 10.1016/j.neuron.2020.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.08.022</ArticleId><ArticleId IdType="pmc">PMC7736125</ArticleId><ArticleId IdType="pubmed">32931756</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein C, Westenberger A. Genetics of Parkinson&#x2019;s disease. Cold Spring Harb Perspect Med. 2012;2:a008888&#x2013;a008888. doi: 10.1101/cshperspect.a008888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a008888</ArticleId><ArticleId IdType="pmc">PMC3253033</ArticleId><ArticleId IdType="pubmed">22315721</ArticleId></ArticleIdList></Reference><Reference><Citation>Klockgether T, Mariotti C, Paulson HL. Spinocerebellar ataxia. Nat Rev Dis Primers. 2019;5:24. doi: 10.1038/s41572-019-0074-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-019-0074-3</ArticleId><ArticleId IdType="pubmed">30975995</ArticleId></ArticleIdList></Reference><Reference><Citation>Knupp A, Mishra S, Martinez R, et al. Depletion of the AD risk gene SORL1 selectively impairs neuronal endosomal traffic independent of amyloidogenic app processing. Cell Rep. 2020;31:107719. doi: 10.1016/j.celrep.2020.107719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.107719</ArticleId><ArticleId IdType="pmc">PMC7409533</ArticleId><ArticleId IdType="pubmed">32492427</ArticleId></ArticleIdList></Reference><Reference><Citation>Kouroupi G, Taoufik E, Vlachos IS, et al. Defective synaptic connectivity and axonal neuropathology in a human iPSC-based model of familial Parkinson&#x2019;s disease. Proc Natl Acad Sci USA. 2017;114:E3679&#x2013;E3688. doi: 10.1073/pnas.1617259114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1617259114</ArticleId><ArticleId IdType="pmc">PMC5422768</ArticleId><ArticleId IdType="pubmed">28416701</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan G, Zhang Y, Gu Y, et al. CRISPR deletion of the C9ORF72 promoter in ALS/FTD patient motor neurons abolishes production of dipeptide repeat proteins and rescues neurodegeneration. Acta Neuropathol. 2020;140:81&#x2013;84. doi: 10.1007/s00401-020-02154-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-020-02154-6</ArticleId><ArticleId IdType="pmc">PMC7300081</ArticleId><ArticleId IdType="pubmed">32266467</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam D, Enright HA, Cadena J, et al. Tissue-specific extracellular matrix accelerates the formation of neural networks and communities in a neuron-glia co-culture on a multi-electrode array. Sci Rep. 2019;9:4159. doi: 10.1038/s41598-019-40128-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-40128-1</ArticleId><ArticleId IdType="pmc">PMC6411890</ArticleId><ArticleId IdType="pubmed">30858401</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert E, Saha O, Soares Landeira B, et al. The Alzheimer susceptibility gene BIN1 induces isoform-dependent neurotoxicity through early endosome defects. Acta Neuropathol Commun. 2022;10:4. doi: 10.1186/s40478-021-01285-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-021-01285-5</ArticleId><ArticleId IdType="pmc">PMC8742943</ArticleId><ArticleId IdType="pubmed">34998435</ArticleId></ArticleIdList></Reference><Reference><Citation>Langbehn DR, Hayden MR, Paulsen JS, and the PREDICT-HD Investigators of the Huntington Study Group CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches. Am J Med Genet. 2010;153B:397&#x2013;408. doi: 10.1002/ajmg.b.30992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.b.30992</ArticleId><ArticleId IdType="pmc">PMC3048807</ArticleId><ArticleId IdType="pubmed">19548255</ArticleId></ArticleIdList></Reference><Reference><Citation>Laverde-Paz MJ, Nuytemans K, Wang L et al (2021) Derivation of stem cell line UMi028-A-2 containing a CRISPR/Cas9 induced Alzheimer&#x2019;s disease risk variant p.S1038C in the TTC3 gene. Stem Cell Res 52:102258. 10.1016/j.scr.2021.102258</Citation><ArticleIdList><ArticleId IdType="pubmed">33626494</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C, Willerth SM, Nygaard HB. The use of patient-derived induced pluripotent stem cells for Alzheimer&#x2019;s disease modeling. Prog Neurobiol. 2020;192:101804. doi: 10.1016/j.pneurobio.2020.101804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2020.101804</ArticleId><ArticleId IdType="pubmed">32464173</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehnen D, Barral S, Cardoso T, et al. IAP-based cell sorting results in homogeneous transplantable dopaminergic precursor cells derived from human pluripotent stem cells. Stem Cell Rep. 2017;9:1207&#x2013;1220. doi: 10.1016/j.stemcr.2017.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.08.016</ArticleId><ArticleId IdType="pmc">PMC5639383</ArticleId><ArticleId IdType="pubmed">28943253</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Yu W, Huang S, et al. Structure-guided engineering of adenine base editor with minimized RNA off-targeting activity. Nat Commun. 2021;12:2287. doi: 10.1038/s41467-021-22519-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22519-z</ArticleId><ArticleId IdType="pmc">PMC8052359</ArticleId><ArticleId IdType="pubmed">33863894</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J-J, Lin X, Tang C, et al. Disruption of splicing-regulatory elements using CRISPR/Cas9 to rescue spinal muscular atrophy in human iPSCs and mice. Natl Sci Rev. 2020;7:92&#x2013;101. doi: 10.1093/nsr/nwz131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nsr/nwz131</ArticleId><ArticleId IdType="pmc">PMC8446915</ArticleId><ArticleId IdType="pubmed">34691481</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Zhu L, Xiao B, et al. CRISPR-Cpf1-mediated genome editing and gene regulation in human cells. Biotechnol Adv. 2019;37:21&#x2013;27. doi: 10.1016/j.biotechadv.2018.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biotechadv.2018.10.013</ArticleId><ArticleId IdType="pubmed">30399413</ArticleId></ArticleIdList></Reference><Reference><Citation>Li JX, Valadez AV, Zuo P, Nie Z. Microfluidic 3D cell culture: potential application for tissue-based bioassays. Bioanalysis. 2012;4:1509&#x2013;1525. doi: 10.4155/bio.12.133.</Citation><ArticleIdList><ArticleId IdType="doi">10.4155/bio.12.133</ArticleId><ArticleId IdType="pmc">PMC3909686</ArticleId><ArticleId IdType="pubmed">22793034</ArticleId></ArticleIdList></Reference><Reference><Citation>Liguori F, Amadio S, Volont&#xe9; C. Fly for ALS: Drosophila modeling on the route to amyotrophic lateral sclerosis modifiers. Cell Mol Life Sci. 2021 doi: 10.1007/s00018-021-03905-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-021-03905-8</ArticleId><ArticleId IdType="pubmed">34322715</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim WF, Forouhan M, Roberts TC et al (2021) Gene therapy with AR isoform 2 rescues spinal and bulbar muscular atrophy phenotype by modulating AR transcriptional activity. Sci Adv 7:eabi6896. 10.1126/sciadv.abi6896</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8378820</ArticleId><ArticleId IdType="pubmed">34417184</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L, G&#xf6;ke J, Cukuroglu E, et al. Molecular features underlying neurodegeneration identified through in vitro modeling of genetically diverse Parkinson&#x2019;s disease patients. Cell Rep. 2016;15:2411&#x2013;2426. doi: 10.1016/j.celrep.2016.05.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.05.022</ArticleId><ArticleId IdType="pubmed">27264186</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y-T, Seo J, Gao F, et al. APOE4 causes widespread molecular and cellular alterations associated with Alzheimer&#x2019;s disease phenotypes in human iPSC-derived brain cell types. Neuron. 2018;98:1141&#x2013;1154.e7. doi: 10.1016/j.neuron.2018.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.05.008</ArticleId><ArticleId IdType="pmc">PMC6023751</ArticleId><ArticleId IdType="pubmed">29861287</ArticleId></ArticleIdList></Reference><Reference><Citation>Lines G, Casey JM, Preza E, Wray S. Modelling frontotemporal dementia using patient-derived induced pluripotent stem cells. Mol Cell Neurosci. 2020;109:103553. doi: 10.1016/j.mcn.2020.103553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2020.103553</ArticleId><ArticleId IdType="pubmed">32956830</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S-C, Polymenidou M, Cleveland DW. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron. 2013;79:416&#x2013;438. doi: 10.1016/j.neuron.2013.07.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.07.033</ArticleId><ArticleId IdType="pmc">PMC4411085</ArticleId><ArticleId IdType="pubmed">23931993</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C-C, Kanekiyo T, Xu H, Bu G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol. 2013;9:106&#x2013;118. doi: 10.1038/nrneurol.2012.263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2012.263</ArticleId><ArticleId IdType="pmc">PMC3726719</ArticleId><ArticleId IdType="pubmed">23296339</ArticleId></ArticleIdList></Reference><Reference><Citation>Makarova KS, Wolf YI, Alkhnbashi OS, et al. An updated evolutionary classification of CRISPR&#x2013;Cas systems. Nat Rev Microbiol. 2015;13:722&#x2013;736. doi: 10.1038/nrmicro3569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro3569</ArticleId><ArticleId IdType="pmc">PMC5426118</ArticleId><ArticleId IdType="pubmed">26411297</ArticleId></ArticleIdList></Reference><Reference><Citation>Malankhanova T, Suldina L, Grigor&#x2019;eva E, et al. A human induced pluripotent stem cell-derived isogenic model of Huntington&#x2019;s disease based on neuronal cells has several relevant phenotypic abnormalities. JPM. 2020;10:215. doi: 10.3390/jpm10040215.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm10040215</ArticleId><ArticleId IdType="pmc">PMC7712151</ArticleId><ArticleId IdType="pubmed">33182269</ArticleId></ArticleIdList></Reference><Reference><Citation>Marschallinger J, Iram T, Zardeneta M, et al. Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat Neurosci. 2020;23:194&#x2013;208. doi: 10.1038/s41593-019-0566-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0566-1</ArticleId><ArticleId IdType="pmc">PMC7595134</ArticleId><ArticleId IdType="pubmed">31959936</ArticleId></ArticleIdList></Reference><Reference><Citation>Marthaler AG, Schmid B, Tubsuwan A, et al. Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H271. Stem Cell Res. 2016;16:180&#x2013;183. doi: 10.1016/j.scr.2015.12.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2015.12.028</ArticleId><ArticleId IdType="pubmed">27345809</ArticleId></ArticleIdList></Reference><Reference><Citation>Masrori P, Van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020;27:1918&#x2013;1929. doi: 10.1111/ene.14393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>McColgan P, Tabrizi SJ. Huntington&#x2019;s disease: a clinical review. Eur J Neurol. 2018;25:24&#x2013;34. doi: 10.1111/ene.13413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13413</ArticleId><ArticleId IdType="pubmed">28817209</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta A, Merkel OM. Immunogenicity of Cas9 protein. J Pharm Sci. 2020;109:62&#x2013;67. doi: 10.1016/j.xphs.2019.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xphs.2019.10.003</ArticleId><ArticleId IdType="pmc">PMC7115921</ArticleId><ArticleId IdType="pubmed">31589876</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R, Flynn LL, Pitout IL, et al. ALS genetics, mechanisms, and therapeutics: where are we now? Front Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirza M, Vainshtein A, DiRonza A et al (2019) The CLN3 gene and protein: what we know. Mol Genet Genomic Med 7.&#xa0;10.1002/mgg3.859</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6900386</ArticleId><ArticleId IdType="pubmed">31568712</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitalipov S, Wolf D. Totipotency, pluripotency and nuclear reprogramming. In: Martin U, editor. Engineering of Stem Cells. Berlin Heidelberg, Berlin, Heidelberg: Springer; 2009. pp. 185&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2752493</ArticleId><ArticleId IdType="pubmed">19343304</ArticleId></ArticleIdList></Reference><Reference><Citation>Modell AE, Lim D, Nguyen TM, et al. CRISPR-based therapeutics: current challenges and future applications. Trends Pharmacol Sci. 2022;43:151&#x2013;161. doi: 10.1016/j.tips.2021.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2021.10.012</ArticleId><ArticleId IdType="pubmed">34952739</ArticleId></ArticleIdList></Reference><Reference><Citation>Moussaud S, Jones DR, Moussaud-Lamodi&#xe8;re EL, et al. Alpha-synuclein and tau: teammates in neurodegeneration? Mol Neurodegeneration. 2014;9:43. doi: 10.1186/1750-1326-9-43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-9-43</ArticleId><ArticleId IdType="pmc">PMC4230508</ArticleId><ArticleId IdType="pubmed">25352339</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullin S, Hughes D, Mehta A, Schapira AHV. Neurological effects of glucocerebrosidase gene mutations. Eur J Neurol. 2019;26:388&#x2013;e29. doi: 10.1111/ene.13837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13837</ArticleId><ArticleId IdType="pmc">PMC6492454</ArticleId><ArticleId IdType="pubmed">30315684</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagoshi N, Okano H, Nakamura M. Regenerative therapy for spinal cord injury using iPSC technology. Inflamm Regener. 2020;40:40. doi: 10.1186/s41232-020-00149-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41232-020-00149-0</ArticleId><ArticleId IdType="pmc">PMC7565344</ArticleId><ArticleId IdType="pubmed">33088363</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HN, Byers B, Cord B, et al. LRRK2 mutant iPSC-derived DA neurons demonstrate increased susceptibility to oxidative stress. Cell Stem Cell. 2011;8:267&#x2013;280. doi: 10.1016/j.stem.2011.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2011.01.013</ArticleId><ArticleId IdType="pmc">PMC3578553</ArticleId><ArticleId IdType="pubmed">21362567</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HP, Van Broeckhoven C, van der Zee J. ALS genes in the genomic era and their implications for FTD. Trends Genet. 2018;34:404&#x2013;423. doi: 10.1016/j.tig.2018.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2018.03.001</ArticleId><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishizono H, Yasuda R, Laviv T. Methodologies and challenges for CRISPR/Cas9 mediated genome editing of the mammalian brain. Front Genome Ed. 2020;2:602970. doi: 10.3389/fgeed.2020.602970.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgeed.2020.602970</ArticleId><ArticleId IdType="pmc">PMC8525404</ArticleId><ArticleId IdType="pubmed">34713226</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xf3;brega C, Pereira de Almeida L, editors. Polyglutamine disorders. Cham: Springer International Publishing; 2018.</Citation></Reference><Reference><Citation>Oksanen M, Petersen AJ, Naumenko N, et al. PSEN1 mutant iPSC-derived model reveals severe astrocyte pathology in Alzheimer&#x2019;s disease. Stem Cell Rep. 2017;9:1885&#x2013;1897. doi: 10.1016/j.stemcr.2017.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.10.016</ArticleId><ArticleId IdType="pmc">PMC5785689</ArticleId><ArticleId IdType="pubmed">29153989</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira LMA, Falomir-Lockhart LJ, Botelho MG, et al. Elevated &#x3b1;-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson&#x2019;s patient-derived induced pluripotent stem cells. Cell Death Dis. 2015;6:e1994&#x2013;e1994. doi: 10.1038/cddis.2015.318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2015.318</ArticleId><ArticleId IdType="pmc">PMC4670926</ArticleId><ArticleId IdType="pubmed">26610207</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz-Virumbrales M, Moreno CL, Kruglikov I et al (2017) CRISPR/Cas9-correctable mutation-related molecular and physiological phenotypes in iPSC-derived Alzheimer&#x2019;s PSEN2 N141I neurons. Acta Neuropathol Commun 5:77. 10.1186/s40478-017-0475-z</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5660456</ArticleId><ArticleId IdType="pubmed">29078805</ArticleId></ArticleIdList></Reference><Reference><Citation>Osaki T, Uzel SGM, Kamm RD (2018) Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS-derived muscle cells and optogenetic motor neurons. Sci Adv 4:eaat5847. 10.1126/sciadv.aat5847</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6179377</ArticleId><ArticleId IdType="pubmed">30324134</ArticleId></ArticleIdList></Reference><Reference><Citation>Oura S, Noda T, Morimura N, et al. Precise CAG repeat contraction in a Huntington&#x2019;s disease mouse model is enabled by gene editing with SpCas9-NG. Commun Biol. 2021;4:771. doi: 10.1038/s42003-021-02304-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02304-w</ArticleId><ArticleId IdType="pmc">PMC8222283</ArticleId><ArticleId IdType="pubmed">34163001</ArticleId></ArticleIdList></Reference><Reference><Citation>Ouyang S, Xie Y, Xiong Z, et al. CRISPR/Cas9-targeted deletion of polyglutamine in spinocerebellar ataxia type 3-derived induced pluripotent stem cells. Stem Cells Dev. 2018;27:756&#x2013;770. doi: 10.1089/scd.2017.0209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/scd.2017.0209</ArticleId><ArticleId IdType="pubmed">29661116</ArticleId></ArticleIdList></Reference><Reference><Citation>Paff M, Loh A, Sarica C et al (2020) Update on current technologies for deep brain stimulation in Parkinson&#x2019;s disease. JMD 13:185&#x2013;198. 10.14802/jmd.20052</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7502302</ArticleId><ArticleId IdType="pubmed">32854482</ArticleId></ArticleIdList></Reference><Reference><Citation>Paik DT, Tian L, Lee J, et al. Large-scale single-cell RNA-Seq reveals molecular signatures of heterogeneous populations of human induced pluripotent stem cell-derived endothelial cells. Circ Res. 2018;123:443&#x2013;450. doi: 10.1161/CIRCRESAHA.118.312913.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.118.312913</ArticleId><ArticleId IdType="pmc">PMC6202208</ArticleId><ArticleId IdType="pubmed">29986945</ArticleId></ArticleIdList></Reference><Reference><Citation>Patterson K, Linask KL, Beers J, Zou J. Generation of two tdTomato reporter induced pluripotent stem cell lines (NHLBIi003-A-1 and NHLBIi003-A-2) by AAVS1 safe harbor gene-editing. Stem Cell Research. 2020;42:101673. doi: 10.1016/j.scr.2019.101673.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2019.101673</ArticleId><ArticleId IdType="pmc">PMC7046126</ArticleId><ArticleId IdType="pubmed">31869686</ArticleId></ArticleIdList></Reference><Reference><Citation>Penney J, Ralvenius WT, Tsai L-H. Modeling Alzheimer&#x2019;s disease with iPSC-derived brain cells. Mol Psychiatry. 2020;25:148&#x2013;167. doi: 10.1038/s41380-019-0468-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-019-0468-3</ArticleId><ArticleId IdType="pmc">PMC6906186</ArticleId><ArticleId IdType="pubmed">31391546</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira JD, DuBreuil DM, Devlin A-C, et al. Human sensorimotor organoids derived from healthy and amyotrophic lateral sclerosis stem cells form neuromuscular junctions. Nat Commun. 2021;12:4744. doi: 10.1038/s41467-021-24776-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24776-4</ArticleId><ArticleId IdType="pmc">PMC8346474</ArticleId><ArticleId IdType="pubmed">34362895</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez RG. Editorial: The protein alpha-synuclein: its normal role (in neurons) and its role in disease. Front Neurosci. 2020;14:116. doi: 10.3389/fnins.2020.00116.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00116</ArticleId><ArticleId IdType="pmc">PMC7044239</ArticleId><ArticleId IdType="pubmed">32153354</ArticleId></ArticleIdList></Reference><Reference><Citation>Poewe W, Seppi K, Tanner CM et al (2017) Parkinson disease. Nat Rev Dis Primers 3:17013. 10.1038/nrdp.2017.13</Citation><ArticleIdList><ArticleId IdType="pubmed">28332488</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon A, Saini H, Sethi S, et al. The role of SQSTM1 (p62) in mitochondrial function and clearance in human cortical neurons. Stem Cell Rep. 2021;16:1276&#x2013;1289. doi: 10.1016/j.stemcr.2021.03.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.03.030</ArticleId><ArticleId IdType="pmc">PMC8185463</ArticleId><ArticleId IdType="pubmed">33891871</ArticleId></ArticleIdList></Reference><Reference><Citation>Qing X, Walter J, Jarazo J, et al. CRISPR/Cas9 and piggyBac-mediated footprint-free LRRK2-G2019S knock-in reveals neuronal complexity phenotypes and &#x3b1;-Synuclein modulation in dopaminergic neurons. Stem Cell Res. 2017;24:44&#x2013;50. doi: 10.1016/j.scr.2017.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2017.08.013</ArticleId><ArticleId IdType="pubmed">28826027</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G, Bede P, Marchand-Pauvert V, Pradat P-F. Biomarkers of spinal and bulbar muscle atrophy (SBMA): a comprehensive review. Front Neurol. 2018;9:844. doi: 10.3389/fneur.2018.00844.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00844</ArticleId><ArticleId IdType="pmc">PMC6191472</ArticleId><ArticleId IdType="pubmed">30364135</ArticleId></ArticleIdList></Reference><Reference><Citation>Ray A, Joshi JM, Sundaravadivelu PK, et al. An overview on promising somatic cell sources utilized for the efficient generation of induced pluripotent stem cells. Stem Cell Rev Rep. 2021 doi: 10.1007/s12015-021-10200-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-021-10200-3</ArticleId><ArticleId IdType="pubmed">34100193</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins JP, Perfect L, Ribe EM et al (2018)&#xa0;Clusterin is required for &#x3b2;-amyloid toxicity in human iPSC-derived neurons. Front Neurosci 12.&#xa0;10.3389/fnins.2018.00504</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6068261</ArticleId><ArticleId IdType="pubmed">30090055</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodr&#xed;guez Cruz PM, Cossins J, Beeson D, Vincent A. The neuromuscular junction in health and disease: molecular mechanisms governing synaptic formation and homeostasis. Front Mol Neurosci. 2020;13:610964. doi: 10.3389/fnmol.2020.610964.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2020.610964</ArticleId><ArticleId IdType="pmc">PMC7744297</ArticleId><ArticleId IdType="pubmed">33343299</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos RA. Huntington&#x2019;s disease: a clinical review. Orphanet J Rare Dis. 2010;5:40. doi: 10.1186/1750-1172-5-40.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-5-40</ArticleId><ArticleId IdType="pmc">PMC3022767</ArticleId><ArticleId IdType="pubmed">21171977</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross CA, Tabrizi SJ. Huntington&#x2019;s disease: from molecular pathogenesis to clinical treatment. Lancet Neurol. 2011;10:83&#x2013;98. doi: 10.1016/S1474-4422(10)70245-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70245-3</ArticleId><ArticleId IdType="pubmed">21163446</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruggeri FS, Flagmeier P, Kumita JR, et al. The influence of pathogenic mutations in &#x3b1;-synuclein on biophysical and structural characteristics of amyloid fibrils. ACS Nano. 2020;14:5213&#x2013;5222. doi: 10.1021/acsnano.9b09676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsnano.9b09676</ArticleId><ArticleId IdType="pubmed">32159944</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan SD, Dolatabadi N, Chan SF, et al. Isogenic human iPSC Parkinson&#x2019;s model shows nitrosative stress-induced dysfunction in MEF2-PGC1&#x3b1; transcription. Cell. 2013;155:1351&#x2013;1364. doi: 10.1016/j.cell.2013.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.11.009</ArticleId><ArticleId IdType="pmc">PMC4028128</ArticleId><ArticleId IdType="pubmed">24290359</ArticleId></ArticleIdList></Reference><Reference><Citation>Safari F, Zare K, Negahdaripour M, et al. CRISPR Cpf1 proteins: structure, function and implications for genome editing. Cell Biosci. 2019;9:36. doi: 10.1186/s13578-019-0298-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-019-0298-7</ArticleId><ArticleId IdType="pmc">PMC6507119</ArticleId><ArticleId IdType="pubmed">31086658</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha B, Borgohain MP, Dey C, Thummer RP. iPS cell generation: current and future challenges. Annals Stem Cell Res Ther. 2018;1:4.</Citation></Reference><Reference><Citation>Saha B, Krishna Kumar H, Borgohain MP, Thummer RP. Prospective applications of induced pluripotent stem cells in military medicine. Med J Armed Forces India. 2018;74:313&#x2013;320. doi: 10.1016/j.mjafi.2018.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mjafi.2018.03.005</ArticleId><ArticleId IdType="pmc">PMC6224643</ArticleId><ArticleId IdType="pubmed">30449915</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez-Dan&#xe9;s A, Richaud-Patin Y, Carballo-Carbajal I, et al. Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson&#x2019;s disease. EMBO Mol Med. 2012;4:380&#x2013;395. doi: 10.1002/emmm.201200215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201200215</ArticleId><ArticleId IdType="pmc">PMC3403296</ArticleId><ArticleId IdType="pubmed">22407749</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos R, Vadodaria KC, Jaeger BN, et al. Differentiation of inflammation-responsive astrocytes from glial progenitors generated from human induced pluripotent stem cells. Stem Cell Rep. 2017;8:1757&#x2013;1769. doi: 10.1016/j.stemcr.2017.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.05.011</ArticleId><ArticleId IdType="pmc">PMC5470172</ArticleId><ArticleId IdType="pubmed">28591655</ArticleId></ArticleIdList></Reference><Reference><Citation>Sareen D, O&#x2019;Rourke JG, Meera P et al (2013) Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci Transl Med 5:208ra149&#x2013;208ra149. 10.1126/scitranslmed.3007529</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4090945</ArticleId><ArticleId IdType="pubmed">24154603</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt O, Teis D. The ESCRT machinery. Curr Biol. 2012;22:R116&#x2013;R120. doi: 10.1016/j.cub.2012.01.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cub.2012.01.028</ArticleId><ArticleId IdType="pmc">PMC3314914</ArticleId><ArticleId IdType="pubmed">22361144</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt CE, Morales BM, Schmitz EMH, et al. Fluorescent tagged episomals for stoichiometric induced pluripotent stem cell reprogramming. Stem Cell Res Ther. 2017;8:132. doi: 10.1186/s13287-017-0581-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-017-0581-7</ArticleId><ArticleId IdType="pmc">PMC5460403</ArticleId><ArticleId IdType="pubmed">28583172</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulte J, Littleton JT. The biological function of the Huntingtin protein and its relevance to Huntington&#x2019;s Disease pathology. Curr Trends Neurol. 2011;5:65&#x2013;78. doi: 10.1038/nrn1806.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1806</ArticleId><ArticleId IdType="pmc">PMC3237673</ArticleId><ArticleId IdType="pubmed">22180703</ArticleId></ArticleIdList></Reference><Reference><Citation>Seirafi M, Kozlov G, Gehring K. Parkin structure and function. FEBS J. 2015;282:2076&#x2013;2088. doi: 10.1111/febs.13249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.13249</ArticleId><ArticleId IdType="pmc">PMC4672691</ArticleId><ArticleId IdType="pubmed">25712550</ArticleId></ArticleIdList></Reference><Reference><Citation>Selkoe DJ, Peter J Lansbury J (1999) Alzheimer&#x2019;s disease is the most common neurodegenerative disorder. Basic Neurochemistry: Molecular, Cellular and Medical Aspects 6th edition</Citation></Reference><Reference><Citation>Seminary ER, Sison SL, Ebert AD. Modeling protein aggregation and the heat shock response in ALS iPSC-derived motor neurons. Front Neurosci. 2018;12:86. doi: 10.3389/fnins.2018.00086.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00086</ArticleId><ArticleId IdType="pmc">PMC5826239</ArticleId><ArticleId IdType="pubmed">29515358</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi C, Mao C, Zhang S, et al. CHCHD2 gene mutations in familial and sporadic Parkinson&#x2019;s disease. Neurobiol Aging. 2016;38:217.e9&#x2013;217.e13. doi: 10.1016/j.neurobiolaging.2015.10.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.10.040</ArticleId><ArticleId IdType="pubmed">26705026</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin JW, Kim K-H, Chao MJ et al (2016) Permanent inactivation of Huntington&#x2019;s disease mutation by personalized allele-specific CRISPR/Cas9. Hum Mol Genet ddw286. 10.1093/hmg/ddw286</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6078600</ArticleId><ArticleId IdType="pubmed">28172889</ArticleId></ArticleIdList></Reference><Reference><Citation>Shulman JM, De Jager PL, Feany MB. Parkinson&#x2019;s disease: genetics and pathogenesis. Annu Rev Pathol Mech Dis. 2011;6:193&#x2013;222. doi: 10.1146/annurev-pathol-011110-130242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathol-011110-130242</ArticleId><ArticleId IdType="pubmed">21034221</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidransky E, Lopez G. The link between the GBA gene and parkinsonism. Lancet Neurol. 2012;11:986&#x2013;998. doi: 10.1016/S1474-4422(12)70190-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70190-4</ArticleId><ArticleId IdType="pmc">PMC4141416</ArticleId><ArticleId IdType="pubmed">23079555</ArticleId></ArticleIdList></Reference><Reference><Citation>Siller R, Greenhough S, Park I-H, Sullivan GJ Modelling human disease with pluripotent stem cells. CGT. 2013;13:99&#x2013;110. doi: 10.2174/1566523211313020004.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1566523211313020004</ArticleId><ArticleId IdType="pmc">PMC3785403</ArticleId><ArticleId IdType="pubmed">23444871</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh PK, Muqit MMK. Parkinson&#x2019;s: a disease of aberrant vesicle trafficking. Annu Rev Cell Dev Biol. 2020;36:237&#x2013;264. doi: 10.1146/annurev-cellbio-100818-125512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-cellbio-100818-125512</ArticleId><ArticleId IdType="pubmed">32749865</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh VK, Kalsan M, Kumar N et al (2015) Induced pluripotent stem cells: applications in regenerative medicine, disease modeling, and drug discovery. Front Cell Dev Biol 3.&#xa0;10.3389/fcell.2015.00002</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4313779</ArticleId><ArticleId IdType="pubmed">25699255</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith KR, Damiano J, Franceschetti S, et al. Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage. Am J Hum Genet. 2012;90:1102&#x2013;1107. doi: 10.1016/j.ajhg.2012.04.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2012.04.021</ArticleId><ArticleId IdType="pmc">PMC3370276</ArticleId><ArticleId IdType="pubmed">22608501</ArticleId></ArticleIdList></Reference><Reference><Citation>Soldner F, Hockemeyer D, Beard C, et al. Parkinson&#x2019;s disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell. 2009;136:964&#x2013;977. doi: 10.1016/j.cell.2009.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.02.013</ArticleId><ArticleId IdType="pmc">PMC2787236</ArticleId><ArticleId IdType="pubmed">19269371</ArticleId></ArticleIdList></Reference><Reference><Citation>Soldner F, Stelzer Y, Shivalila CS, et al. Parkinson-associated risk variant in distal enhancer of &#x3b1;-synuclein modulates target gene expression. Nature. 2016;533:95&#x2013;99. doi: 10.1038/nature17939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature17939</ArticleId><ArticleId IdType="pmc">PMC5042324</ArticleId><ArticleId IdType="pubmed">27096366</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonninen T-M, H&#xe4;m&#xe4;l&#xe4;inen RH, Koskuvi M, et al. Metabolic alterations in Parkinson&#x2019;s disease astrocytes. Sci Rep. 2020;10:14474. doi: 10.1038/s41598-020-71329-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-71329-8</ArticleId><ArticleId IdType="pmc">PMC7468111</ArticleId><ArticleId IdType="pubmed">32879386</ArticleId></ArticleIdList></Reference><Reference><Citation>Spataro R, Kousi M, Farhan SMK, et al. Mutations in ATP13A2 (PARK9) are associated with an amyotrophic lateral sclerosis-like phenotype, implicating this locus in further phenotypic expansion. Hum Genomics. 2019;13:19. doi: 10.1186/s40246-019-0203-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40246-019-0203-9</ArticleId><ArticleId IdType="pmc">PMC6469102</ArticleId><ArticleId IdType="pubmed">30992063</ArticleId></ArticleIdList></Reference><Reference><Citation>Sriram S, Kang N-Y, Subramanian S, et al. Novel live cell fluorescent probe for human-induced pluripotent stem cells highlights early reprogramming population. Stem Cell Res Ther. 2021;12:113. doi: 10.1186/s13287-021-02171-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-021-02171-6</ArticleId><ArticleId IdType="pmc">PMC7866770</ArticleId><ArticleId IdType="pubmed">33546754</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava T, Raj R, Dubey A, et al. Fast kinetics of environmentally induced &#x3b1;-synuclein aggregation mediated by structural alteration in NAC region and result in structure dependent cytotoxicity. Sci Rep. 2020;10:18412. doi: 10.1038/s41598-020-75361-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-75361-6</ArticleId><ArticleId IdType="pmc">PMC7591854</ArticleId><ArticleId IdType="pubmed">33110167</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanis L. &#x3b1;-Synuclein in Parkinson&#x2019;s disease. Cold Spring Harb Perspect Med. 2012;2:a009399&#x2013;a009399. doi: 10.1101/cshperspect.a009399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a009399</ArticleId><ArticleId IdType="pmc">PMC3281589</ArticleId><ArticleId IdType="pubmed">22355802</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoklund Dittlau K, Krasnow EN, Fumagalli L et al (2021) Human motor units in microfluidic devices are impaired by FUS mutations and improved by HDAC6 inhibition. Stem Cell Rep S2213671121001600.&#xa0;10.1016/j.stemcr.2021.03.029</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8452598</ArticleId><ArticleId IdType="pubmed">33891869</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ (ed) (2012) Amyotrophic lateral sclerosis and the frontotemporal dementias. Oxford University Press</Citation></Reference><Reference><Citation>Sugai K, Sumida M, Shofuda T, et al. First-in-human clinical trial of transplantation of iPSC-derived NS/PCs in subacute complete spinal cord injury: study protocol. Regen Ther. 2021;18:321&#x2013;333. doi: 10.1016/j.reth.2021.08.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.reth.2021.08.005</ArticleId><ArticleId IdType="pmc">PMC8427225</ArticleId><ArticleId IdType="pubmed">34522725</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundaravadivelu PK, Raina K, Thool M, et al. Advances in Experimental Medicine and Biology. Cham: Springer International Publishing; 2021. Tissue-restricted stem cells as starting cell source for efficient generation of pluripotent stem cells: an overview; pp. 1&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">34611861</ArticleId></ArticleIdList></Reference><Reference><Citation>Tada M, Coon EA, Osmand AP, et al. Coexistence of Huntington&#x2019;s disease and amyotrophic lateral sclerosis: a clinicopathologic study. Acta Neuropathol. 2012;124:749&#x2013;760. doi: 10.1007/s00401-012-1005-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1005-5</ArticleId><ArticleId IdType="pmc">PMC3545711</ArticleId><ArticleId IdType="pubmed">22735976</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi J. iPS cell-based therapy for Parkinson&#x2019;s disease: a Kyoto trial. Regen Ther. 2020;13:18&#x2013;22. doi: 10.1016/j.reth.2020.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.reth.2020.06.002</ArticleId><ArticleId IdType="pmc">PMC7794047</ArticleId><ArticleId IdType="pubmed">33490319</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861&#x2013;872. doi: 10.1016/j.cell.2007.11.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.11.019</ArticleId><ArticleId IdType="pubmed">18035408</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663&#x2013;676. doi: 10.1016/j.cell.2006.07.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.07.024</ArticleId><ArticleId IdType="pubmed">16904174</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang C, Han J, Dalvi S, et al. A human model of batten disease shows role of CLN3 in phagocytosis at the photoreceptor&#x2013;RPE interface. Commun Biol. 2021;4:161. doi: 10.1038/s42003-021-01682-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-01682-5</ArticleId><ArticleId IdType="pmc">PMC7864947</ArticleId><ArticleId IdType="pubmed">33547385</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang S, Xie M, Cao N, Ding S. Patient-specific induced pluripotent stem cells for disease modeling and phenotypic drug discovery: miniperspective. J Med Chem. 2016;59:2&#x2013;15. doi: 10.1021/acs.jmedchem.5b00789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jmedchem.5b00789</ArticleId><ArticleId IdType="pubmed">26322868</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian R, Gachechiladze MA, Ludwig CH, et al. CRISPR interference-based platform for multimodal genetic screens in human iPSC-derived neurons. Neuron. 2019;104:239&#x2013;255.e12. doi: 10.1016/j.neuron.2019.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.07.014</ArticleId><ArticleId IdType="pmc">PMC6813890</ArticleId><ArticleId IdType="pubmed">31422865</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran J, Anastacio H, Bardy C (2020) Genetic predispositions of Parkinson&#x2019;s disease revealed in patient-derived brain cells. npj Parkinsons Dis 6:8. 10.1038/s41531-020-0110-8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7181694</ArticleId><ArticleId IdType="pubmed">32352027</ArticleId></ArticleIdList></Reference><Reference><Citation>Trapecar M, Wogram E, Svoboda D et al (2021) Human physiomimetic model integrating microphysiological systems of the gut, liver, and brain for studies of neurodegenerative diseases. Sci Adv 7:eabd1707. 10.1126/sciadv.abd1707</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7846169</ArticleId><ArticleId IdType="pubmed">33514545</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xdc;berbacher C (2019) Application of CRISPR/Cas9 editing and digital droplet PCR in human iPSCs to generate novel knock-in reporter lines to visualize dopaminergic neurons. Stem Cell Res 10.&#xa0;10.1016/j.scr.2019.101656</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7322529</ArticleId><ArticleId IdType="pubmed">31733438</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugbode C, West RJH. Lessons learned from CHMP2B, implications for frontotemporal dementia and amyotrophic lateral sclerosis. Neurobiol Dis. 2021;147:105144. doi: 10.1016/j.nbd.2020.105144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.105144</ArticleId><ArticleId IdType="pubmed">33144171</ArticleId></ArticleIdList></Reference><Reference><Citation>Valadez-Barba V, Cota-Coronado A, Hern&#xe1;ndez-P&#xe9;rez OR, et al. iPSC for modeling neurodegenerative disorders. Regen Ther. 2020;15:332&#x2013;339. doi: 10.1016/j.reth.2020.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.reth.2020.11.006</ArticleId><ArticleId IdType="pmc">PMC7770414</ArticleId><ArticleId IdType="pubmed">33426236</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdez C, Wong YC, Schwake M, et al. Progranulin-mediated deficiency of cathepsin D results in FTD and NCL-like phenotypes in neurons derived from FTD patients. Hum Mol Genet. 2017;26:4861&#x2013;4872. doi: 10.1093/hmg/ddx364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx364</ArticleId><ArticleId IdType="pmc">PMC5886207</ArticleId><ArticleId IdType="pubmed">29036611</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, Hardiman O, Chio A, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2013;2098. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#xe1;zquez-V&#xe9;lez GE, Zoghbi HY. Parkinson&#x2019;s disease genetics and pathophysiology. Annu Rev Neurosci. 2021;44:87&#x2013;108. doi: 10.1146/annurev-neuro-100720-034518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-neuro-100720-034518</ArticleId><ArticleId IdType="pubmed">34236893</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma A, Verma M, Singh A (2020) Animal tissue culture principles and applications. In: Animal Biotechnology. Elsevier, pp 269&#x2013;293</Citation></Reference><Reference><Citation>Vethe H, Bj&#xf8;rlykke Y, Ghila LM, et al. Probing the missing mature &#x3b2;-cell proteomic landscape in differentiating patient iPSC-derived cells. Sci Rep. 2017;7:4780. doi: 10.1038/s41598-017-04979-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-04979-w</ArticleId><ArticleId IdType="pmc">PMC5500592</ArticleId><ArticleId IdType="pubmed">28684784</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Najm R, Xu Q, et al. Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat Med. 2018;24:647&#x2013;657. doi: 10.1038/s41591-018-0004-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0004-z</ArticleId><ArticleId IdType="pmc">PMC5948154</ArticleId><ArticleId IdType="pubmed">29632371</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Zhang M, Garcia G, et al. ApoE-isoform-dependent SARS-CoV-2 neurotropism and cellular response. Cell Stem Cell. 2021;28:331&#x2013;342.e5. doi: 10.1016/j.stem.2020.12.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.12.018</ArticleId><ArticleId IdType="pmc">PMC7832490</ArticleId><ArticleId IdType="pubmed">33450186</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Yi F, Fu L, et al. CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs. Protein Cell. 2017;8:365&#x2013;378. doi: 10.1007/s13238-017-0397-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-017-0397-3</ArticleId><ArticleId IdType="pmc">PMC5413600</ArticleId><ArticleId IdType="pubmed">28401346</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Zhang J, Liao J, et al. Donor genetic backgrounds contribute to the functional heterogeneity of stem cells and clinical outcomes. STEM CELLS Transl Med. 2020;9:1495&#x2013;1499. doi: 10.1002/sctm.20-0155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sctm.20-0155</ArticleId><ArticleId IdType="pmc">PMC7695629</ArticleId><ArticleId IdType="pubmed">32830917</ArticleId></ArticleIdList></Reference><Reference><Citation>White RB, Thomas MG (2012) Moving beyond tyrosine hydroxylase to define dopaminergic neurons for use in cell replacement therapies for Parkinson&#x2019;s disease. CNSNDDT 11:340&#x2013;349. 10.2174/187152712800792758</Citation><ArticleIdList><ArticleId IdType="pubmed">22483315</ArticleId></ArticleIdList></Reference><Reference><Citation>W&#xf6;rdehoff MM, Bannach O, Shaykhalishahi H, et al. Single fibril growth kinetics of &#x3b1;-synuclein. J Mol Biol. 2015;427:1428&#x2013;1435. doi: 10.1016/j.jmb.2015.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2015.01.020</ArticleId><ArticleId IdType="pubmed">25659910</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu L, Rosa-Neto P, Hsiung G-YR, et al. Early-onset familial Alzheimer&#x2019;s disease (EOFAD) Can J Neurol Sci. 2012;39:436&#x2013;445. doi: 10.1017/S0317167100013949.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0317167100013949</ArticleId><ArticleId IdType="pubmed">22728850</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y, Zhang J, Shu X, et al. Loss of mitochondrial protein CHCHD10 in skeletal muscle causes neuromuscular junction impairment. Hum Mol Genet. 2020;29:1784&#x2013;1796. doi: 10.1093/hmg/ddz154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddz154</ArticleId><ArticleId IdType="pubmed">31261376</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu X, Tay Y, Sim B, et al. Reversal of phenotypic abnormalities by CRISPR/Cas9-mediated gene correction in Huntington disease patient-derived induced pluripotent stem cells. Stem Cell Rep. 2017;8:619&#x2013;633. doi: 10.1016/j.stemcr.2017.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.01.022</ArticleId><ArticleId IdType="pmc">PMC5355646</ArticleId><ArticleId IdType="pubmed">28238795</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagi T, Ito D, Okada Y, et al. Modeling familial Alzheimer&#x2019;s disease with induced pluripotent stem cells. Hum Mol Genet. 2011;20:4530&#x2013;4539. doi: 10.1093/hmg/ddr394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr394</ArticleId><ArticleId IdType="pubmed">21900357</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye T, Duan Y, Tsang HWS, et al. Efficient manipulation of gene dosage in human iPSCs using CRISPR/Cas9 nickases. Commun Biol. 2021;4:195. doi: 10.1038/s42003-021-01722-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-01722-0</ArticleId><ArticleId IdType="pmc">PMC7881037</ArticleId><ArticleId IdType="pubmed">33580208</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin R-H, Yu J-T, Tan L. The role of SORL1 in Alzheimer&#x2019;s disease. Mol Neurobiol. 2015;51:909&#x2013;918. doi: 10.1007/s12035-014-8742-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-8742-5</ArticleId><ArticleId IdType="pubmed">24833601</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshihara M, Hayashizaki Y, Murakawa Y. Genomic instability of iPSCs: challenges towards their clinical applications. Stem Cell Rev Rep. 2017;13:7&#x2013;16. doi: 10.1007/s12015-016-9680-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-016-9680-6</ArticleId><ArticleId IdType="pmc">PMC5346115</ArticleId><ArticleId IdType="pubmed">27592701</ArticleId></ArticleIdList></Reference><Reference><Citation>Young W (2012) Patient-specific induced pluripotent stem cells as a platform for disease modeling, drug discovery and precision personalized medicine. J Stem Cell Res Ther 1.&#xa0;10.4172/2157-7633.S10-010</Citation></Reference><Reference><Citation>Yu J, Vodyanik MA, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917&#x2013;1920. doi: 10.1126/science.1151526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1151526</ArticleId><ArticleId IdType="pubmed">18029452</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J-T, Tan L. The role of clusterin in Alzheimer&#x2019;s disease: pathways, pathogenesis, and therapy. Mol Neurobiol. 2012;45:314&#x2013;326. doi: 10.1007/s12035-012-8237-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-012-8237-1</ArticleId><ArticleId IdType="pubmed">22274961</ArticleId></ArticleIdList></Reference><Reference><Citation>Yucel N, Blau HM (2019) Skeletal muscle stem cells. In: Principles of Regenerative Medicine. Elsevier, pp 273&#x2013;293</Citation></Reference><Reference><Citation>Yun Y, Hong S-A, Kim K-K, et al. CRISPR-mediated gene correction links the ATP7A M1311V mutations with amyotrophic lateral sclerosis pathogenesis in one individual. Commun Biol. 2020;3:33. doi: 10.1038/s42003-020-0755-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-020-0755-1</ArticleId><ArticleId IdType="pmc">PMC6970999</ArticleId><ArticleId IdType="pubmed">31959876</ArticleId></ArticleIdList></Reference><Reference><Citation>Yusa K. Seamless genome editing in human pluripotent stem cells using custom endonuclease&#x2013;based gene targeting and the piggyBac transposon. Nat Protoc. 2013;8:2061&#x2013;2078. doi: 10.1038/nprot.2013.126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2013.126</ArticleId><ArticleId IdType="pubmed">24071911</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng L, Zhang D, McLoughlin HS, et al. Loss of the Spinocerebellar Ataxia type 3 disease protein ATXN3 alters transcription of multiple signal transduction pathways. PLoS ONE. 2018;13:e0204438. doi: 10.1371/journal.pone.0204438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0204438</ArticleId><ArticleId IdType="pmc">PMC6145529</ArticleId><ArticleId IdType="pubmed">30231063</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N, An MC, Montoro D, Ellerby LM (2010) Characterization of human Huntington&#x2019;s disease cell model from induced pluripotent stem cells. PLoS Curr 2.&#xa0;10.1371/currents.RRN1193</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2966296</ArticleId><ArticleId IdType="pubmed">21037797</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X-H, Tee LY, Wang X-G et al (2015) Off-target effects in CRISPR/Cas9-mediated genome engineering. Mol Ther - Nucleic Acids 4:e264. 10.1038/mtna.2015.37</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4877446</ArticleId><ArticleId IdType="pubmed">26575098</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Schmid B, Nikolaisen NK, et al. Patient iPSC-derived neurons for disease modeling of frontotemporal dementia with mutation in CHMP2B. Stem Cell Rep. 2017;8:648&#x2013;658. doi: 10.1016/j.stemcr.2017.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.01.012</ArticleId><ArticleId IdType="pmc">PMC5355623</ArticleId><ArticleId IdType="pubmed">28216144</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M, Hu Z, Qiu L, et al. Seamless genetic conversion of SMN2 to SMN1 via CRISPR/Cpf1 and single-stranded oligodeoxynucleotides in spinal muscular atrophy patient-specific induced pluripotent stem cells. Hum Gene Ther. 2018;29:1252&#x2013;1263. doi: 10.1089/hum.2017.255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hum.2017.255</ArticleId><ArticleId IdType="pubmed">29598153</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>